IBDEI279 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37311,1,3,0)
 ;;=3^Bursopathies, oth site, oth, spec
 ;;^UTILITY(U,$J,358.3,37311,1,4,0)
 ;;=4^M71.88
 ;;^UTILITY(U,$J,358.3,37311,2)
 ;;=^5133868
 ;;^UTILITY(U,$J,358.3,37312,0)
 ;;=M71.89^^140^1787^78
 ;;^UTILITY(U,$J,358.3,37312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37312,1,3,0)
 ;;=3^Bursopathies, multpl sites, oth, spec
 ;;^UTILITY(U,$J,358.3,37312,1,4,0)
 ;;=4^M71.89
 ;;^UTILITY(U,$J,358.3,37312,2)
 ;;=^5013231
 ;;^UTILITY(U,$J,358.3,37313,0)
 ;;=R76.0^^140^1787^213
 ;;^UTILITY(U,$J,358.3,37313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37313,1,3,0)
 ;;=3^Raised antibody titer
 ;;^UTILITY(U,$J,358.3,37313,1,4,0)
 ;;=4^R76.0
 ;;^UTILITY(U,$J,358.3,37313,2)
 ;;=^5019569
 ;;^UTILITY(U,$J,358.3,37314,0)
 ;;=R76.9^^140^1787^2
 ;;^UTILITY(U,$J,358.3,37314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37314,1,3,0)
 ;;=3^Abnl immunological fndgs in serum, unspec
 ;;^UTILITY(U,$J,358.3,37314,1,4,0)
 ;;=4^R76.9
 ;;^UTILITY(U,$J,358.3,37314,2)
 ;;=^5019573
 ;;^UTILITY(U,$J,358.3,37315,0)
 ;;=M31.7^^140^1787^192
 ;;^UTILITY(U,$J,358.3,37315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37315,1,3,0)
 ;;=3^Microscopic polyangiitis
 ;;^UTILITY(U,$J,358.3,37315,1,4,0)
 ;;=4^M31.7
 ;;^UTILITY(U,$J,358.3,37315,2)
 ;;=^5011749
 ;;^UTILITY(U,$J,358.3,37316,0)
 ;;=M31.4^^140^1787^58
 ;;^UTILITY(U,$J,358.3,37316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37316,1,3,0)
 ;;=3^Aortic arch syndrome [Takayasu]
 ;;^UTILITY(U,$J,358.3,37316,1,4,0)
 ;;=4^M31.4
 ;;^UTILITY(U,$J,358.3,37316,2)
 ;;=^5011746
 ;;^UTILITY(U,$J,358.3,37317,0)
 ;;=I77.6^^140^1787^59
 ;;^UTILITY(U,$J,358.3,37317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37317,1,3,0)
 ;;=3^Arteritis, unspec
 ;;^UTILITY(U,$J,358.3,37317,1,4,0)
 ;;=4^I77.6
 ;;^UTILITY(U,$J,358.3,37317,2)
 ;;=^5007813
 ;;^UTILITY(U,$J,358.3,37318,0)
 ;;=M26.62^^140^1787^60
 ;;^UTILITY(U,$J,358.3,37318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37318,1,3,0)
 ;;=3^Arthralgia of temporomandibular joint
 ;;^UTILITY(U,$J,358.3,37318,1,4,0)
 ;;=4^M26.62
 ;;^UTILITY(U,$J,358.3,37318,2)
 ;;=^270034
 ;;^UTILITY(U,$J,358.3,37319,0)
 ;;=M12.9^^140^1787^61
 ;;^UTILITY(U,$J,358.3,37319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37319,1,3,0)
 ;;=3^Arthropathy, unspec
 ;;^UTILITY(U,$J,358.3,37319,1,4,0)
 ;;=4^M12.9
 ;;^UTILITY(U,$J,358.3,37319,2)
 ;;=^5010666
 ;;^UTILITY(U,$J,358.3,37320,0)
 ;;=M35.2^^140^1787^62
 ;;^UTILITY(U,$J,358.3,37320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37320,1,3,0)
 ;;=3^Behcet's disease
 ;;^UTILITY(U,$J,358.3,37320,1,4,0)
 ;;=4^M35.2
 ;;^UTILITY(U,$J,358.3,37320,2)
 ;;=^263705
 ;;^UTILITY(U,$J,358.3,37321,0)
 ;;=I82.91^^140^1787^94
 ;;^UTILITY(U,$J,358.3,37321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37321,1,3,0)
 ;;=3^Chron embolism & thrombosis of unspec vein
 ;;^UTILITY(U,$J,358.3,37321,1,4,0)
 ;;=4^I82.91
 ;;^UTILITY(U,$J,358.3,37321,2)
 ;;=^5007941
 ;;^UTILITY(U,$J,358.3,37322,0)
 ;;=M1A.30X1^^140^1787^152
 ;;^UTILITY(U,$J,358.3,37322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37322,1,3,0)
 ;;=3^Gout, chron d/t renal imprmnt, unsp site, w/ tophus (tophi)
 ;;^UTILITY(U,$J,358.3,37322,1,4,0)
 ;;=4^M1A.30X1
 ;;^UTILITY(U,$J,358.3,37322,2)
 ;;=^5010960
 ;;^UTILITY(U,$J,358.3,37323,0)
 ;;=M1A.9XX1^^140^1787^156
 ;;^UTILITY(U,$J,358.3,37323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37323,1,3,0)
 ;;=3^Gout, chron, unspec, w/ tophus (tophi)
 ;;^UTILITY(U,$J,358.3,37323,1,4,0)
 ;;=4^M1A.9XX1
 ;;^UTILITY(U,$J,358.3,37323,2)
 ;;=^5133773
 ;;^UTILITY(U,$J,358.3,37324,0)
 ;;=Z79.52^^140^1787^190
 ;;^UTILITY(U,$J,358.3,37324,1,0)
 ;;=^358.31IA^4^2
